StockNews.AI
RMD
StockNews.AI
139 days

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

1. Resmed will release Q3 2025 results on April 23, 2025. 2. A webcast will follow the earnings release for further discussion. 3. Resmed focuses on innovative health technologies for better patient care. 4. Forward-looking information may be shared during the webcast session.

Earnings
-4.33%Current Return
VS
-4.93%S&P 500
$22304/02 05:35 PM EDTEvent Start
$213.3504/03 11:58 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

Upcoming earnings reports can typically lead to volatility, based on market expectations.

How important is it?

The upcoming earnings report is likely to influence investor sentiment significantly.

Why Short Term?

Earnings announcements usually influence immediate market reactions, impacting share price short-term.

Related Companies

HSICTMO
April 02, 2025 16:05 ET  | Source: Resmed, Inc. SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:  •Location:https://investor.resmed.com •Date:Wednesday, April 23, 2025 •Time:1:30 p.m. PDT / 4:30 p.m. EDT •International:London, Wednesday, April 23, 2025, 9:30 p.m. BST   Sydney, Thursday, April 24, 2025, 6:30 a.m. AEST Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only. A replay of the earnings webcast will be accessible on Resmed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 23, 2025, until May 7, 2025, at:  •U.S.: +1 877.660.6853 •International: +1 201.612.7415 •Conference ID: 13752711 About ResmedResmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

Related News